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Background: Retinoblastoma (Rb) is the most common intraocular tumor in childhood worldwide. It is a deadly
pediatric eye cancer. The main cause of death in Rb patients is intracranial and systemic metastasis. ROCK is the
main downstream effector of Ras-homologous (Rho) family of GTPases which are involved in many cellular functions,
such as cell proliferation, invasion and metastasis. Overexpression of ROCK promotes invasion and metastasis of many
solid tumors. However, the effect of ROCK in Rb is largely unknown.
Methods: ROCK-1 and ROCK-2 mRNA expression in Y79 cell lines were examined by RT-PCR. Protein expression in the
Y79 cell line were examined by western blot analyses. ROCK-1 and ROCK-2 siRNA were transfected into Y79 cells with
Lipofectamine 2000. Cell proliferation was evaluated by CCK-8 assay after exposure to ROCK inhibitor (Y-27632). We
examined the effect of ROCK inhibitors (Y-27632, ROCK-1 and ROCK-2 siRNA) on Y79 cell adhesive capacity by cell
adhesion assay. Cell invasion assay through matrigel was used to study the effect of ROCK inhibitors on Y79 cell invasive
capacity.
Results: The expression of mRNA of ROCK-1 was more than that of ROCK-2 in the Y79 cell line. The protein expression
levels of ROCK-1 and ROCK-2 were downregulated in the cells transfected with siRNA. Y-27632 treatment didn’t lead to
any changes of Y79 cells proliferation. Adhesive ability of Y79 cells was enhanced following Y-27632 or ROCK-1 siRNA
treatment. The invasive capacity of Y79 cells showed an inverse relationship with increasing Y-27632 concentration.
Invasiveness of Y79 cells also decreased in Y79 cells transfected with ROCK-1 siRNA. However, there was no change in
adhesive ability or invasive capacity in Y79 cells transfected with siRNA against ROCK-2.
Conclusions: The findings of this study demonstrate that ROCK-1 protein plays a key role in regulating metastasis and
invasion of Y79 cells, suggesting that the ROCK-1 dependent pathway may be a potential target for therapy of Rb.
Keywords: Adhesion, Invasion, Retinoblastoma, ROCKBackground
Retinoblastoma (Rb) is a deadly pediatric eye cancer. The
mortality rate among children diagnosed with Rb is 50%
to 70% in the underdeveloped countries, and it is the most
common intraocular tumor in childhood worldwide [1].
Children with Rb are at risk for three life-threatening
problems, including metastasis of Rb, intracranial neuro-
blastic malignancy (trilateral Rb), and second primary
tumors [2].* Correspondence: brinkleybing@126.com; yszhong68@126.com
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unless otherwise stated.The changes of motility are among the initial events of
invasion and metastasis. Dynamic reorganization of the
actin and tubulin cytoskeleton facilitate cell movement
[3,4]. Among the signaling pathways participating in regu-
lating invasion and metastasis of cancer cells, Rho associ-
ated kinase (ROCK) signaling pathway plays a key role in
the process [5]. To date, two ROCK isoforms have been
described, namely ROCK-1 and ROCK-2. They are highly
homologous, sharing 65% of the entire in amino acid se-
quence and 92% of the sequence in their kinase domains
[6]. ROCK is the main downstream effector of Ras-
homologous (Rho) family of GTPases which are involved
in many cellular functions, such as cell proliferation,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ROCK promotes invasion and metastasis in many solid tu-
mors, such as hepatocellular, breast and colon cancers
[8-11]. Therefore, inhibition of ROCK could be a potential
therapeutic approach for these tumors.
Y-27632 is a well-established pharmacological inhibitor
displaying a high specificity for ROCK proteins [12]. Y-
27632 treatment decreases invasion of cultured melan-
oma and other tumor cells [13,14]. However, the effect
of ROCK inhibition in Rb is largely unknown. In this
study, we investigated the effect of ROCK pathway in-
hibition by using Y-27632 and ROCK siRNA on prolifer-
ation and motility of Rb cells.
Methods
Cell lines and cell culture
RbY79 cell line was obtained from ATCC. RPMI 1640 media
and fetal bovine serum (FBS) were purchased from Life
Technologies Corporation. Y79 cells were cultured in RPMI
1640 medium supplemented with 15% heat-inactivated FBS,
0.1% ciprofloxacin, 2 mM L-glutamine, 1 mM sodium pyru-
vate, and 4.5% dextrose. The cells were grown in 25 cm2 cul-
ture flasks in the upright position in 10 mL aliquots of the
culture medium. Incubation was performed at 37°C under a
humidified atmosphere of 5% CO2-95% air.
siRNA and transfection
The short interfering RNAs (siRNAs) were synthesized
(GenePharma, China) and used for transfection. The sense
and antisense strands of the ROCK-1 siRNA were 5′-G
GCAGAGGAAGAAUAUAAATT −3′ and 5′- UUUAUA
UUCUUCCUCUGCCTT-3′; ROCK-2 siRNA were 5′-G
CAGCUGGAAUCUAACAAUTT-3′ and 5′- AUUGUUA
GAUUCCAGCUGCTT-3′; negative control were 5′-UU
CUCCGAACGUGUCACGUTT-3′ and 5′-ACGUGACA
CGUUCGGAGAATT-3′. (designed and synthesized by
GenePharma Co. Ltd, Shanghai). These siRNA were trans-
fected into Y79 cells with Lipofectamine® 2000 (Invitrogen)
following the manufacturer’s instructions. Briefly, a total of
5 × 105 cells were plated in 6-well plates and transfected
using 100 pmol siRNA and 5 μL of Lipofectamine® 2000
per well. After 24–48 hours of incubation, the cells were
harvested for RT-qPCR or western blots analysis.
RNA isolation and RT-qPCR
Y79 cells transfected with the siRNA were incubated for
24 hours. Cells were harvested for RT-qPCR analysis.
Total RNA was extracted using TRIzol (Invitrogen), and
single-stranded cDNA was synthesized with AMV Reverse
Transcriptase System (Promega) according to the manu-
facturer’s instructions. Real-time quantitative polymerase
chain (RT-qPCR) reactions were done with 10 ng cDNA
in SYBR Green I mix (Takara Bio Inc.) and run on an ABI
Prism 7300 HT 7300 Real-Time PCR System (AppliedBiosystems). For all of cDNA, 40 cycles and annealing
temperature of 60°C (31 seconds) were used. All PCR re-
actions were performed in triplicate. Primer sequences
(designed by primer3 web (version 3.0.0) and synthesized
by Sangon Biotech Co. Ltd, Shanghai) are:
ROCK-1: forward primer 5′-
ACCTGTAACCCAAGGAGATGTG-3′ and reverse
primer 5′- CACAATTGGCAGGAAAGTGG-3′;
ROCK-2: forward primer 5′-AAGTGGGTTAG
TCGGTTG-3′ and reverse primer 5′-GGCAGTTAG
CTAGGTTTG-3′;
β-actin: forward primer 5′-GGGACCTGACT
GACTACCTCA-3′ and reverse primer 5′-GACTCGT
CATACTCCTGCTTG-3′. Commercial software
(SDS version 1.3; ABI) was used to calculate 2^-ΔΔCt
relative expression values for ROCK-1 and ROCK-2
normalized to the β-actin endogenous control.
Western blots
Y79 cells transfected with the siRNA were incubated for
48 hours. Cells were harvested for western blots analysis.
Y79 cells were lysed for 5 minutes in cold lysis buffer. After
centrifugation at 12,000 rpm for 5 minutes, the supernatant
was collected as the total cellular protein extracts. The pro-
tein concentration was determined using Bradford method
[15]. The total cellular protein extracts were separated on
8% SDS–PAGE. Proteins were electrotransferred to PVDF
membranes (Millipore, USA) by a semi-dry transferor. The
membranes were blocked in 5% skimmed milk in TBS-T
containing 0.05% Tween 20 at room temperature (RT) for
2 hours, and then incubated at RT for 2 hours with anti-
bodies to ROCK-1, ROCK-2, LIMK2, phospho-LIMK1
Thr508/LIMK2 Thr505, cofilin, phospho-cofilin Ser3
(1:1000, Cell Signaling Technology, Beverly, MA), and
β-actin(1:5000, Cell Signaling Technology, Beverly, MA) di-
luted in 5% bovine serum albumin in TBS-T, respectively,
followed by incubating with the appropriate HRP-linked
secondary antibodies. Finally, the bands of specific proteins
on the membranes were developed with Western Blotting
Luminal Reagent (Millipore, USA) and quantified with
Image J software (National Institutes of Health, USA).
Cell proliferation assay
Cell proliferation was detected by a Cell Counting Kit-8
(Beyotime, Jiangsu, China) assay. Y79 cells were suspended
in RPMI 1640 medium supplemented with 15% heat-
inactivated fetal bovine serum and subsequently seeded in
96-well plates and incubated for 24 h. After that, we added
medium containing Y-27632 ((R)-(+)-trans-N-(4-Pyridyl)-4-
(1-aminoethyl)- cyclohexanecarboxamide.2HCl, purchased
from Enzo Life Sciences, Inc.) in 10, 50, 100 μM,
Figure 1 ROCK-1 and ROCK-2 mRNA expression in Y79 cell lines. (A) ROCK-1 and ROCK-2 mRNA expression in Y79 cell (*P < 0.05, n = 3).
(B) ROCK-1 mRNA level in Y79 cell in blank control group, negtive control group and ROCK-1 siRNA group (*P < 0.05, n = 3). (C) ROCK-2 mRNA
level in Y79 cell in blank control group, negtive control group and ROCK-2 siRNA group (*P < 0.05, n = 3).
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10 μl CCK-8 solution to each well and incubated at 37°C
for another 2 hours. Optical density (OD) value of absorb-
ance at 450 nm was measured by Thermo Scientific
Fluoroskan Ascent FL (Thermo Fisher Scientific Inc.).
The results were plotted as means ± SD of three inde-
pendent experiments having three determinations per
sample for each experiment.
Cell adhesion assay
The effects of Y-27632 on the adhesion ability of Y79
cells to ECM were examined using the adhesion assay.
The binding of Y79 cells to matrigel were investigated. A
96-well plate was coated with matrigel (2 ug/50 μl). Cells
(4 × 105 cells, cultured in RPMI 1640 medium supple-
mented with 10% FBS) were seeded onto these compo-
nents in 96-well Plate. Y-27632 was diluted at the
concentration of 10 μM, 20 μM, 30 μM, 50 μM, 100 μM.
The cells were treated for 1 h. They were allowed to ad-
here to each well for 30 min at 37°C and then gently
washed twice in PBS. The adhesion Y79 cells wereFigure 2 ROCK-1 and ROCK-2 protein expression in Y79 cell lines. (A)
(B) Western blotting shows the marked decrease in the band intensity of t
negative control siRNA treatment (*P < 0.05, n = 3). (C) Western blotting sh
with ROCK-2 siRNA for 48 hours compared to negative control siRNA treatmquantified by the Cell Counting Kit-8 assay according to
the manufacturer’s instructions.
To study the effects of ROCK siRNA on cell adhesion,
three groups of Y79 cells were transfected for 24 hr with
control siRNA, ROCK-1 siRNA, or ROCK-2 siRNA,
respectively. The cells in the forth group were treated with
Y-27632 at 30 μM. Untransfected cells and cells transfected
with control siRNA served as controls. Cells (4 × 105 cells)
were allowed to adhere to each well for 30 min at 37°C and
then gently washed twice in PBS. The adhesion Y79 cells
were quantified by the Cell Counting Kit-8 assay.
Cell invasion assay
The 24-well plate Transwell system with a polycarbonate
filter membrane of 8-mm pore size (Corning Inc.) was
used to detect invasive capacity changes of Y79 cells. The
Matrigel (BD Biosciences) layers were rehydrated for
2 hours at RT by adding 100 μL of serum-free media to
the upper compartment. After rehydration, the media
were removed from the upper compartment of the inva-
sion chamber. Cell suspension containing 1 × 106 cells/mLROCK-1 and ROCK-2 protein expression in Y79 cell (*P < 0.05, n = 3).
he Y79 cells treated with ROCK-1 siRNA for 48 hours compared to
ows the marked decrease in the band intensity of the Y79 cells treated
ent (*P < 0.05, n = 3).
Figure 3 Effects of Y-27632 concentration on cell of Y79 cell
proliferation. The OD value of CCK-8 assay shows no difference
in cell proliferation of Y79 cells at various Y-27632 doses
(*P < 0.05, n = 5).
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medium supplemented with 15% FBS were added to each
of the lower compartments and 100 μL of the cell suspen-
sion were added to each of the upper compartments. After
incubating for 48 hours at 37°C, invasive cells in lower
compartments of the chamber were counted by Cell
Counting Kit-8 assay.
The six groups of Y79 cells were treated with Y-27632
at 0, 10 μM, 20 μM, 30 μM, 40 μM, 50 μM, respectively.
After incubating for 48 h at 37°C, invasive cells in lower
compartments of the chamber were counted by Cell
Counting Kit-8 assay. To study the effects of ROCK
siRNA on cell invasion, three groups of Y79 cells were
transfected for 24 hr with control siRNA, ROCK-1 siRNA,
or ROCK-2 siRNA, respectively. The cells in the forth
group were treated with Y-27632 at 30 μM. Untransfected
cells and cells transfected with control siRNA served as
controls. After incubating for 48 h, invasive cells in lower
compartments of the chamber were counted by Cell
Counting Kit-8 assay.Figure 4 Effects of Y-27632 and ROCK siRNA on adhesion capacity of
Compared with the control group, adhesion capacity increased with increa
the cells treated with blank control, negative control siRNA, ROCK-1 siRNA,Statistical analyses
All experiments were repeated at least three times. Inde-
pendent t-test analysis was used for statistical analysis be-
tween two groups, and the comparisons among multiple
groups were made with a one-way analysis of variance
(ANOVA) followed by Dunnett’s t test. (SPSS Statisics
19.0). The differences were considered significant for P
values of < 0.05.
Result
Expressions of ROCK-1 and ROCK-2 in Y79 cell lines
ROCK-1 and ROCK-2 mRNA expression in Y79 cell
lines were examined by RT-qPCR.
The expression of mRNA of ROCK-1 was about twice
as much as that of ROCK-2 ( 2^-ΔΔCt = 0.48 ± 0.03, P <
0.05) (Figure 1A). Treatment of Y79 cells with ROCK-1
siRNA for 24 hours reduced ROCK-1 mRNA levels
against blank controls (2^-ΔΔCt = 0.38 ± 0.03, P < 0.05)
and negative controls (2^-ΔΔCt = 0.40 ± 0.02, P < 0.05)
(Figure 1B). Treatment of Y79 cells with ROCK-2 siRNA
for 24 hours reduced ROCK-2 mRNA levels against blank
controls (2^-ΔΔCt = 0.45 ± 0.05, P < 0.05) and negative
controls (2^-ΔΔCt = 0.48 ± 0.05, P < 0.05) (Figure 1C).
Protein expression in Y79 cell line that received siRNA
treatment for ROCK-1 and ROCK-2 were examined by
using western blot analyses. Cells transfected with control
siRNA were used as controls. The protein expression
levels of ROCK-1 and ROCK-2 were reduced in the cells
transfected with siRNA against ROCK-1 and ROCK-2,
respectively, compared with the control cells (Figure 2).
Effects of Y-27632 on cell proliferation of Y79 cells
To investigate the effects of ROCK inhibition on cellular
proliferation of Rb cells, cell proliferation was evaluated
by CCK-8 assay after exposure to various Y-27632 doses.
Y-27632 treatment didn’t show any changes of Y79 cells
proliferation (P > 0.05) (Figure 3). These results showed
that ROCK inhibitor Y-27632 didn’t influence prolifera-
tion of Rb cell in vitro.Y79 cells. (A) Effects of Y-27632 on adhesion capacity of Y79 cells.
sing Y-27632 concentration (*P < 0.05, n = 3). (B) Adhesion capacity of
ROCK-1 siRNA, and y-27632 at 30 μM (*P < 0.05, n = 3).
Figure 5 Effects of Y-27632 and ROCK siRNA on invasive capacity of Y79 cells. (A) Effects of Y-27632 on invasion capacity of Y79 cells.
Compared with the control group, invasion capacity decreased with increasing Y-27632 concentration (*P < 0.05, n = 3). (B) Invasion capacity of
the cells treated with blank control, negative control siRNA, ROCK-1 siRNA, ROCK-1 siRNA, and y-27632 at 30 μM (*P < 0.05, n = 3).
Wang et al. BMC Cancer 2014, 14:89 Page 5 of 7
http://www.biomedcentral.com/1471-2407/14/89Effects of Y-27632 and ROCK siRNA on adhesion capacity
of Y79 cells
The Y-27632 dosage-dependent effect on Y79 cell adhe-
sion capacity was studied. The adhesion capacity showed
a positive correlation with increasing Y-27632 concen-
tration (Figure 4A). The OD value of cells transfected
with ROCK-1 siRNA were increased, comparing with
blank and negative control group (P < 0.05) (Figure 4B),
but it was similar to cells treated with Y-27632 at 30 μM
(P > 0.05). There was no statistical difference between
the cells transfected with ROCK-2 siRNA and negative
control group (P > 0.05).
Effects of Y-27632 and ROCK siRNA on invasive capacity
of Y79 cells
The Y-27632 dosage-dependent effect on Y79 cell inva-
sion capacity was studied. After 48 hours incubation at
37°C, the invasion capacity showed an inverse relation-
ship with increasing Y-27632 concentration (Figure 5A).
The OD value of cells transfected with ROCK-1 siRNAFigure 6 Y-27632 or ROCK-1 siRNA inhibits LIMK2/cofilin pathway. Eff
pathway by Western blot analysis, Y-27632 or ROCK-1 siRNA could inhibit twere decreased, comparing with blank and negative con-
trol group (P < 0.05) (Figure 5B), but it was similar to cells
treated with Y-27632 at 30 μM (P > 0.05). There was no
statistical difference between the cells transfected with
ROCK-2 siRNA and negative control group (P > 0.05).
Y-27632 and ROCK siRNA inhibits the phosphorylation of
LIMK2 and Cofilin
We investigated the effects of Y-27632 and ROCK
siRNA on the ROCK/LIMK2/cofilin signaling pathway
by Western blot analysis. As we expected, Y-27632 or
ROCK-1 siRNA could inhibit the levels of LIMK2 and
cofilin phosphorylation in Y79 cells (Figure 6).
Discussion
ROCK-1 and ROCK-2 are serine/threonine kinases and
work as effectors of RhoA, a small GTPase [16]. RhoA/
ROCK pathway has been shown to work multifunctionally
in various cell behaviors [6]. ROCK-1 is expressed ubiqui-
tously, while ROCK-2 is expressed mainly in the brain,ects of Y-27632 and ROCK siRNA on the ROCK/LIMK2/cofilin signaling
he levels of LIMK2 and cofilin phosphorylation in Y79 cells (n = 3).
Figure 7 Rho/ROCK-1/LIMK2/cofilin signalling passway. ROCK-1
is downstream effector of Rho. ROCK-1 phosphorylates and activates
LIM-kinase, which in turn phosphorylates and inactivates cofilin, and
that regulates cell adhesion and invasion.
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found that ROCK-1 and ROCK-2 were expressed in Y79
cell lines at both mRNA and protein levels. The expression
of mRNA of ROCK-1 was almost twice as much as that of
ROCK-2. The expression of ROCK-1 and ROCK-2 were
downregulated in the cells transfected with siRNA with
ROCK-1 and ROCK-2 mRNA inhibition.
ROCK-1 and ROCK-2 are the main downstream effectors
of Ras homologous (Rho) family of GTPases. ROCK phos-
phorylates the conserved threonine in the activation loops
of LIM kinase-2 (LIMK2), increasing LIMK activity and the
subsequent phosphorylation of cofilin proteins, which
blocks their F-actin-severing activity [18-20]. ROCK activa-
tion leads to a series of events that promote force gener-
ation and morphological changes. These events contribute
directly to a number of actin-myosin mediated processes,
such as cell motility, adhesion, smooth muscle contraction,
neurite retraction and phagocytosis. In addition, ROCK ki-
nases play roles in proliferation, differentiation, apoptosis
and oncogenic transformation, although these responses
can be cell type-dependent [7,21]. Y-27632 can inhibit both
ROCK-1 and ROCK-2. In the present study, proliferation
of Y79 cells was not altered significantly after treatment of
Y-27632.
Furthermore, ROCKs regulate cell migration in part by
enhancing actomyosin contractility. ROCK activity has
been reported to be required for tail retraction, at least in
monocytes and prostate cancer cells [22,23].
ROCKs can also affect cell migration by limiting the
extent of lamellipodial protrusion, as inhibiting ROCK
or Rho induces the occurrence of membrane ruffles
[24]. In addition, ROCK-mediated activation of LIMKsand subsequent cofilin phosphorylation could affect cell
migration [25], as constitutively active LIMK2 or excess
phosphorylated cofilin inhibit cell polarization by indu-
cing the formation of numerous lamellipodia (Figure 7)
[25]. The cell invasion assay using transwell chambers
showed that invasion ability was decreased in Y79 cells
transfected with ROCK-1 siRNA, and the invasion abil-
ity could also be decreased by Y-27632, however, inva-
sion ability was not decreased in Y79 cells transfected
with siRNA against ROCK-2, indicating that ROCK-1
but not ROCK-2 is involved in invasion ability of Y79
cells. We hypothesized that the reason was lower ex-
pression of ROCK-2 than that of ROCK-1 in Y79 cells.
Taken together, the findings of this study demonstrate
that cell mobility and invasive ablity of Rb could be de-
creased by ROCK-1-inhabitor, Therefore, the ROCK-1-
dependent pathway may be a potential target for therapy
of Rb.
Conclusions
In conclusion, results described in this report suggest
that ROCK-1 protein plays a key role in regulating me-
tastasis and invasion of Y79 cells, Therefore, ROCK-1
dependent pathway may be a potential target for therapy
of Rb.
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